NealDBhatiaMD

Dermatology • San Diego, CA

Physician

Join to view full profile

Dr. Bhatia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhatia's full profile

Already have an account?

Office
9025 Balboa Avenue
Ste 105
San Diego, CA 92123
Phone+1 858-571-6800

Fax+1 858-571-6801

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Dermatology, 1995 - 1998
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1993 - 1995
University of Wisconsin School of Medicine & Public HealthClass of 1993

Certifications & Licensure

CA State Medical License 1998 - 2026
WI State Medical License 1994 - 2025
AZ State Medical License 2003 - 2011
IA State Medical License 1998 - 2001
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology
Fellow (FASDS) American Society for Dermatologic Surgery

Clinical Trials

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Start of enrollment: 2014 Sep 01
Completed
Phase 2
Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face Start of enrollment: 2016 Mar 01
Completed
Phase 2
Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. Start of enrollment: 2016 Apr 27
Completed
Phase 1
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp Start of enrollment: 2017 Mar 01
Withdrawn
Phase 3
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis Start of enrollment: 2017 Apr 12
Completed
Phase 1
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis Start of enrollment: 2021 May 07
Completed
Phase 2
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting.
Neal Bhatia, Jayme Heim, J Gabriel Vasquez, Tina Bhutani, Brad Schenkel
The Journal of Dermatological Treatment. 2024-12-01
Response to Bass et al's "Significant discordance in DermTech test results when paired with histopathology: Caveat emptor".
Lawrence J Green, Brook Brouha, Neal Bhatia
Journal of the American Academy of Dermatology. 2024-09-01
Biomarkers in Cutaneous Keratinocyte Carcinomas.
Erica Montano, Neal Bhatia, Jelena Ostojić
Dermatology and Therapy. 2024-08-01

Lectures

Acne Boot Camp
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
Caribbean Dermatology Symposium, Inc. 8th Annual Coastal Dermatology Symposium
Caribbean Dermatology Symposium, Inc., Napa, California - 9/26/2012

Press Mentions

DermTech Publishes Study Demonstrating Efficacy of Noninvasive Melanoma Test Across All Fitzpatrick Skin Types in JAADNovember 19th, 2024
FDA Expands Approval of Tirbanibulin for Actinic Keratosis on Larger Areas of Face and ScalpJune 11th, 2024
How Health Care Worker Dissatisfaction Is Fueling a New Trend in Health CareDecember 24th, 2022
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow
American Society for Dermatologic Surgery - ASDS
Fellow